Imaging Characteristics of a Follow-up 18F-AV-1451 Scan
NCT02051764
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
44
Enrollment
INDUSTRY
Sponsor class
Stopped
Lower than expected enrollment
Conditions
Alzheimer's Disease
Interventions
DRUG:
Flortaucipir F18
DRUG:
Florbetapir F 18
PROCEDURE:
Brain PET Scan
Sponsor
Avid Radiopharmaceuticals